<?xml version="1.0" encoding="UTF-8"?>
<p>Stroke, as the cornerstone of neurological emergency and a major cause of mortality and disability, should not be neglected at the expense of extreme community and health-care COVID-19-measures.
 <sup>
  <xref rid="bibr46-1756286420932036" ref-type="bibr">46</xref>
 </sup> However, published and anecdotal reports of declining stroke admission volumes are accumulating.
 <sup>
  <xref rid="bibr46-1756286420932036" ref-type="bibr">46</xref>,
  <xref rid="bibr50-1756286420932036" ref-type="bibr">50</xref>
 </sup> Stroke patients with mostly mild symptoms, and for that reason with better chances of recovery if appropriately treated, may be unwilling to seek medical help due to their fear of the virus. Such a practice can significantly narrow down the time-window for available acute treatments and can lead to neurological deterioration, early recurrent stroke and permanent disability.
 <sup>
  <xref rid="bibr5-1756286420932036" ref-type="bibr">5</xref>
 </sup> In light of those data, several stroke centres have come together to design a study protocol with the aim to investigate the worldwide burden of cerebrovascular disease before, during and after SARS-CoV-2 pandemic (CASCADE study).
 <sup>
  <xref rid="bibr45-1756286420932036" ref-type="bibr">45</xref>
 </sup>
</p>
